Loading
Gynecologic Cancer / Supervised, Personalized Exercise Program / Breast Cancer · Interventional Study
ClinicalTrials.gov · August 14, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a registry record for an active, single-arm pilot feasibility trial of supervised exercise in breast and gynecologic cancer survivors. No results are reported; the study is recruiting and will assess feasibility metrics (recruitment, retention, adherence, and completeness of functional testing) over approximately 14 weeks of intervention. Clinicians and researchers should await publication of completed results before interpreting clinical value.
Interventional, Single Group, Open label, Supportive Care purpose. Breast Cancer, Gynecologic Cancer; age from 18 Years. Intervention: Supervised, Personalized Exercise Program. n = 30. 1 site: United States.
This is a registry record for an active, single-arm pilot feasibility trial of supervised exercise in breast and gynecologic cancer survivors. No results are reported; the study is recruiting and will assess feasibility metrics (recruitment, retention, adherence, and completeness of functional testing) over approximately 14 weeks of intervention. Clinicians and researchers should await publication of completed results before interpreting clinical value.
Outcomes are feasibility metrics, not clinical efficacy or safety events.
This pilot is designed to test feasibility, safety, and acceptability of supervised exercise in cancer survivors before a larger trial. Results are not yet available; clinicians should monitor for publication to inform whether a subsequent efficacy trial is warranted.
This is a pilot feasibility trial with no results reported; the registry record describes planned enrollment and methodology only, assessing recruitment, retention, and adherence rather than clinical efficacy.
As stated by the source record.
Quoted from the source exactly as published.
This pilot is designed to test feasibility, safety, and acceptability of supervised exercise in cancer survivors before a larger trial. Results are not yet available; clinicians should monitor for publication to inform whether a subsequent efficacy trial is warranted.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07765927). This is a study registration, not published results. Lead sponsor: Jess S. Gorzelitz. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 30 participants (ESTIMATED). Conditions: Breast Cancer, Gynecologic Cancer. Interventions: OTHER: Supervised, Personalized Exercise Program. Primary outcome measures: Recruitment rate calculated as the number of participants enrolled divided by the number approached or referred over the study period. , Recruitment period which will start at day 1 through two months; Retention rate defined as the proportion of enrolled participants who complete the 12-week intervention and post-intervention assessment. , Pre-assessment/treatment initiation through post-intervention assessment, approximately 14 weeks; Adherence to exercise sessions calculated as the number of completed supervised exercise sessions divided by the number of prescribed sessions. , Pre-assessment/treatment initiation through post-intervention assessment, approximately 14 weeks; Completeness of functional testing procedures defined as the proportion of participants with complete baseline and follow-up fitness assessments. , Pre-assessment/treatment initiation through post-intervention assessment, approximately 14 weeks. Brief summary: The purpose of this pilot study is to test a supervised exercise program for adults with a history of breast or gynecologic cancer to see if it is safe, helpful, and easy to take part in.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.